Jump to navigation

  • IHME
  • GHDx
  • GBD Compare
Home
Main menu
  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
      • IHME Foundations
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
      • GBD 2019 Home
      • GBD 2019 Resources
      • About GBD
      • Call for Collaborators
      • Data Resources
      • Data Visualizations
      • Country Profiles
      • Publications
      • Infographics & Briefs
      • News & Events
      • Acting on Data
        • IHME Foundations
      • Training
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Explore section

News & Events

  • News
  • Commentaries
  • Events
  • Videos
  • Acting on Data
    • IHME Foundations

Acting on Data


2021

March 3, 2021
JAMA Podcast: The future of COVID-19
Acting on data

Listen to IHME director Dr. Chris Murray discuss the future of the COVID-19 pandemic.

February 9, 2021
Ensuring vaccine confidence
Acting on data

Dr. Mokdad discusses the importance of ensuring vaccine access to any individual irrespective of their citizenship status, creating a national vaccination plan that heavily involves participation at the local level, details on the COVID-19 virus mutations, and more. 

trabajadores con cubrebocas preparan castañas asadas
February 3, 2021
Think Global Health: Es Posible Que Nunca Lleguemos a la Inmunidad Colectiva
Acting on data

La vacilación ante la vacuna y otros riesgos de comportamiento reducen la probabilidad de inmunidad colectiva.

January 28, 2021
We May Never Get to COVID-19 Herd Immunity
Acting on data

Vaccine hesitancy and other behavioral risks reduce the likelihood of herd immunity.

January 20, 2021
Maps of Mask Use
Acting on data

Maps of mask usage globally, and specifically in the United States, since April 20, 2020

January 8, 2021
COVID Projections: January 8, 2021 update
Acting on data

This week, IHME has decided not to release new projections due to significant delays in death reporting during and following the holidays.

January 8, 2021
Overcoming vaccine hesitancy
Acting on data

IHME’s COVID-19 projections show that a fast vaccine rollout has the potential to save many lives globally. A fast vaccine rollout will also accelerate our return to normalcy. To date, delays in vaccination have occurred in many countries, including the US. Intensified efforts to ensure faster delivery are critical to slow the course of the pandemic in the coming months. Some countries such as Israel have achieved dramatic gains in vaccination coverage in a short period demonstrating that rapid scale-up is possible.

2020

December 22, 2020
20 IHME Visuals Published in 2020
Acting on data

20 figures from studies that our researchers and collaborators published in journals in 2020, as well as data visualizations, infographics, GIFs and designs from other IHME-affiliated projects.

November 24, 2020
Prevent COVID-19 deaths by prioritizing interventions for Hispanic, Latino, and Black populations in the US
Acting on data

Analysis by IHME comparing the risk of dying from COVID-19 by race and ethnicity confirms that Hispanic, Latino, and Black Americans are more likely to die from COVID-19 than non-Hispanic whites. 

August 18, 2020
Why we must continue wearing masks AND social distancing
Acting on data

The rate of COVID-19 transmission could be significantly decreased by maintaining social distancing and 95% mask use. Explore a simulation that demonstrates several different scenarios.

May 22, 2020
COVID-19 dataviz release notes for week of May 18
Acting on data

Here we summarize two new views that are available for each chart. For a more detailed walk-through, check out this video tutorial.

May 20, 2020
Why our COVID-19 total death projections for the United States more than doubled
Acting on data

With many locations at or past their initial peak in daily deaths, on May 4, we released an adaptation of our model of the initial peak in deaths that links that model to our emerging understanding of disease transmission dynamics. This new hybrid approach between our initial statistical model and a more traditional disease transmission model will enable the exploration of changes in transmission intensity if – or as the data increasingly suggest, when – social distancing mandates are eased and/or human mobility patterns rise.

April 2, 2020
Our COVID-19 forecasting model, otherwise known as “the Chris Murray Model”
Acting on data

The White House recently referenced a new COVID-19 forecasting model created by Dr. Christopher Murray and researchers in Washington state that predicts the state-by-state impact of the coronavirus pandemic on health systems in the United States. That model is our model.

2019

July 10, 2019
What we measure and why
Acting on data

Why do GBD researchers bother to use new and potentially unfamiliar metrics instead of tried-and-true, older ways of discussing disease, like prevalence and incidence? To illustrate how GBD metrics complement other population health metrics, let’s consider some standard public health metrics, and how GBD-specific metrics build on them.

June 20, 2019
Determining tobacco's cost in Arkansas
Acting on data

As part of a recent bipartisan push to enact new anti-tobacco legislation in the state, the Arkansas Center for Health Improvement (ACHI) used data from the Global Burden of Disease study and the Institute for Health Metrics and Evaluation (IHME) to highlight the steep cost of tobacco use in Arkansas. 

May 31, 2019
UNFPA uses Global Burden of Disease metrics for project prioritization
Acting on data

At the United Nations Population Fund (UNFPA), health innovators are using Global Burden of Disease (GBD) metrics to improve child health, increase access to family planning services, and make childbirth safer.

April 15, 2019
Indonesia unveils provincial Burden of Disease study to inform national development plan
Acting on data

On April 4, 2019, the Indonesian Ministry of National Development Planning, known as Bappenas, and the Ministry of Health unveiled findings from a new provincial-level study of burden of disease, which they are using to guide national planning and priority setting.

March 14, 2019
UNICEF data dashboard incorporates Local Burden of Disease data
Acting on data

As a world leader promoting the health of children and mothers, UNICEF and its partners work to save the lives of millions of the world’s most vulnerable, in part by having hyper-local data at their fingertips. Recently, UNICEF and its partners started using maps from the Local Burden of Disease (LBD) project, an initiative led by the Institute for Health Metrics and Evaluation (IHME), in one of their flagship data dashboards, the Equitable Impact Sensitive Tool (EQUIST).

2018

October 26, 2018
The power of models
Acting on data

Every day we encounter and use mathematical models. From producing weather predictions for the week, to calculating a country’s GDP, to estimating the impact of vaccinations, models help us process, represent, and understand the data that describe the workings of the world around us.

October 18, 2018
Communicating GBD to policymakers: UL’s experience with injury data in Vietnam
Acting on data

Underwriters Laboratories focused on home and workplace safety, publishes a Safety Index, an algorithm-based data science initiative to foster safe conditions through scientific applications addressing safety, security, and sustainability challenges. Data is integral to the Safety Index, and UL utilizes data from the Global Burden of Disease study (GBD).

August 27, 2018
Why estimate?
Acting on data

We use more 90,000 data sources in the Global Burden of Disease. Why do we use estimates instead of simply presenting the data points?

August 7, 2018
Accelerating progress toward universal health coverage in Kenya
Acting on data

As part of its Big Four agenda, the government of Kenya is committed to providing universal health coverage by 2022. Global Burden of Disease (GBD) collaborators in Kenya are shedding light on ways that the study can help the country reach this goal.

July 23, 2018
Determining causes of death: How we reclassify miscoded deaths
Acting on data

Knowing what someone died of can be complicated. We often talk and think about death as a singular event. We say, “he died of cancer” or “she died of old age.” In reality, a series of domino effects are often occurring inside the body that lead to someone’s death. 

July 13, 2018
Making GBD data sources speak a universal language
Acting on data

The Global Burden of Disease (GBD) study relies on a lot of data – over 90,000 data sources, in fact. Each of these data sources has their own distinct way of collecting information and measuring health. How do we make these sources speak the same language?

June 14, 2018
What data sources go into the GBD?
Acting on data

Estimates are only as strong as the evidence they are built on. The Global Burden of Disease (GBD) study produces millions of estimates of health around the globe, estimates that are informing real-world policy and implementation. That means that they have to be built on good data, and a lot of it.

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • next ›
  • last »

News & Events

  • News
  • Commentaries
  • Events
  • Videos
  • Acting on Data
    • IHME Foundations

Sign up for IHME News

Stay connected

     

IHME

Institute for Health Metrics and Evaluation

Population Health Building/Hans Rosling Center

3980 15th Ave. NE, Seattle, WA 98195

UW Campus Box #351615

Tel: +1-206-897-2800

Fax: +1-206-897-2899

© 2020 University of Washington

  • Privacy policy
  • Login

  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Projects

  • Global Burden of Disease (GBD)
  • Disease Control Priorities Network (DCPN)
  • ABCE+: A Focus on Antiretroviral Therapy (ART)
  • Access, Bottlenecks, Costs, and Equity (ABCE)
  • Efficacy to Effectiveness
  • Viral Load Pilot
  • Salud Mesoamérica Initiative
  • Improving Methods to Measure Comparable Mortality by Cause
  • Verbal Autopsy (VA)
  • Disease Expenditure (DEX)
  • Local Burden of Disease
  • State-level disease burden initiative in India
  • US Counties Drivers of Health Study
  • University of Washington Center for Health Trends and Forecasts